Description Rybelsus Semaglutide 14mg Tablets – Oral GLP-1 Treatment for Type 2 Diabetes Product Overview Rybelsus Semaglutide 14mg Tablets are a once-daily oral GLP-1 receptor agonist designed to help adults with type 2 diabetes manage their blood sugar levels. As the first tablet form of Semaglutide, Rybelsus provides a needle-free alternative to injectable diabetes treatments, offering convenience and consistent results. This pack contains 30 tablets (one-month supply) and is ideal for long-term blood sugar control. In addition to lowering A1C, Rybelsus may support weight management when combined with a balanced diet and healthy lifestyle. The tablets are taken once a day, on an empty stomach, with a small amount of water—at least 30 minutes before food or other medications. Key Benefits Oral GLP-1 receptor agonist – no injections needed Lowers A1C and supports blood sugar control May aid in weight reduction Convenient once-daily tablet Suitable for adults with type 2 diabetes How to Use Take one Rybelsus 14mg tablet once daily, at least 30 minutes before the first meal, with a small amount of water (no more than 120 mL). Follow your doctor’s instructions closely.
